
Shattuck Labs STTK
€ 4.09
-1.54%
Shattuck Labs Current Ratio | STTK
Current Ratio Jährlich Shattuck Labs
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 10.5 | 7.97 | 10.7 | 7.04 | 11.1 | 20.5 | - | - | - | - | - | - | - | - | - |
Jährliche Entwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 20.5 | 7.04 | 11.3 |
Current Ratio Vierteljährlich Shattuck Labs
| 2026-Q3 | 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 14.5 | 23.1 | 16.2 | 10.5 | 14.2 | 8.76 | 8.05 | 7.97 | 7.38 | 7.15 | 8.35 | 10.7 | 7.38 | 9.24 | 8.87 | 7.04 | 9.48 | 8.72 | 12.6 | 11.1 | 6.29 | 6.93 | 8.82 | 8.92 | 3.9 | 8.92 | 8.92 | 1.48 | 1.48 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Quartalsentwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 23.1 | 1.48 | 9.21 |
Current Ratio anderer Aktien in der Pharmaeinzelhändler
| Name | Current Ratio | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Daré Bioscience
DARE
|
1.1 | $ 0.41 | -9.93 % | $ 4.58 M | ||
|
Fate Therapeutics
FATE
|
8.17 | $ 0.92 | -9.07 % | $ 109 M | ||
|
Greenwich LifeSciences
GLSI
|
1.06 | $ 19.09 | -3.54 % | $ 258 M | ||
|
Halozyme Therapeutics
HALO
|
1.02 | $ 91.28 | -1.89 % | $ 10.9 B | ||
|
Hutchison China MediTech Limited
HCM
|
3.49 | $ 13.18 | -2.04 % | $ 11.3 B | ||
|
Aptorum Group Limited
APM
|
3.81 | - | - | $ 5.72 M | ||
|
iBio
IBIO
|
7.4 | $ 0.83 | 3.01 % | $ 86.4 M | ||
|
Kodiak Sciences
KOD
|
1.81 | $ 97.05 | -0.87 % | $ 5.16 B | ||
|
Karyopharm Therapeutics
KPTI
|
0.27 | $ 0.02 | -56.5 % | $ 219 | ||
|
FSD Pharma
HUGE
|
1.84 | - | 5743.5 % | $ 69.7 M | ||
|
BioAtla
BCAB
|
0.208 | $ 1.74 | 0.64 % | $ 102 M | ||
|
Catalyst Pharmaceuticals
CPRX
|
7.37 | - | - | $ 3.85 B | ||
|
UroGen Pharma Ltd.
URGN
|
0.655 | $ 28.91 | -8.89 % | $ 1.39 B | ||
|
Catalyst Biosciences
CBIO
|
6.97 | $ 13.01 | 0.74 % | $ 1.16 B | ||
|
ARCA biopharma
ABIO
|
29.3 | - | 1052.0 % | $ 415 M | ||
|
ADiTx Therapeutics
ADTX
|
1.31 | - | - | $ 374 | ||
|
Aeterna Zentaris
AEZS
|
1.22 | - | 5.93 % | $ 314 M | ||
|
AgeX Therapeutics
AGE
|
0.995 | - | -10.17 % | $ 12.2 K | ||
|
Aeglea BioTherapeutics
AGLE
|
12.4 | - | - | $ 1.01 B | ||
|
AIkido Pharma
AIKI
|
2.59 | - | 1.93 % | $ 17.4 M | ||
|
Aileron Therapeutics
ALRN
|
3.34 | - | 10.36 % | $ 9.8 M | ||
|
AlloVir
ALVR
|
2.84 | - | 4.14 % | $ 49.1 M | ||
|
Apellis Pharmaceuticals
APLS
|
1.52 | - | - | $ 5.18 B | ||
|
Athira Pharma
ATHA
|
1.43 | - | - | $ 269 M | ||
|
AVROBIO
AVRO
|
26.9 | - | 1083.1 % | $ 745 M | ||
|
AstraZeneca PLC
AZN
|
1.75 | - | - | $ 96.9 B | ||
|
Brainstorm Cell Therapeutics
BCLI
|
0.0929 | - | -2.5 % | $ 5.88 M | ||
|
BeiGene, Ltd.
BGNE
|
2.14 | - | 0.49 % | $ 251 B | ||
|
EyePoint Pharmaceuticals
EYPT
|
6.29 | $ 0.23 | -12.11 % | $ 16.8 K | ||
|
Bio-Path Holdings
BPTH
|
1.04 | - | - | $ 100 K | ||
|
Cara Therapeutics
CARA
|
2.88 | - | -3.03 % | $ 260 M | ||
|
ChromaDex Corporation
CDXC
|
3.56 | - | -0.88 % | $ 598 M | ||
|
Caladrius Biosciences
CLBS
|
5.65 | - | -16.75 % | $ 25.8 M | ||
|
Cyclacel Pharmaceuticals
CYCC
|
11.3 | - | -5.98 % | $ 34.1 M | ||
|
Diffusion Pharmaceuticals
DFFN
|
4.91 | - | 11.68 % | $ 8.97 M | ||
|
Eloxx Pharmaceuticals
ELOX
|
0.307 | - | -5.68 % | $ 8.28 M | ||
|
Enochian Biosciences
ENOB
|
0.524 | - | - | $ 40.5 M | ||
|
Esperion Therapeutics
ESPR
|
0.607 | - | - | $ 661 M | ||
|
Evofem Biosciences
EVFM
|
0.226 | - | 7.55 % | $ 38.1 M | ||
|
Eyenovia
EYEN
|
4.84 | - | 49.81 % | $ 13.2 M | ||
|
FibroGen
FGEN
|
1.04 | - | - | $ 889 M | ||
|
Homology Medicines
FIXX
|
3.13 | - | 0.77 % | $ 53.4 M | ||
|
Amicus Therapeutics
FOLD
|
1.41 | - | - | $ 4.47 B | ||
|
Frequency Therapeutics
FREQ
|
1.83 | - | - | $ 528 M | ||
|
Galecto
GLTO
|
12.9 | - | - | $ 762 M | ||
|
GlycoMimetics
GLYC
|
6.45 | - | 9357.83 % | $ 1.01 B | ||
|
Graybug Vision
GRAY
|
0.672 | - | -11.23 % | $ 9.65 M | ||
|
Galera Therapeutics
GRTX
|
11.2 | - | -32.59 % | $ 7.61 M | ||
|
Happiness Biotech Group Limited
HAPP
|
9.56 | - | 1.35 % | $ 17.8 M | ||
|
Novavax
NVAX
|
0.902 | $ 7.47 | -3.24 % | $ 1.21 B |